Medline undergoes leadership transformation

NORTHFIELD, Ill. – Medline CEO Charlie Mills, President Andy Mills and COO Jim Abrams plan to retire from their current roles after more than 26 years of leadership. 

They will continue to serve on the company’s board of directors, with Charlie Mills leading as chairman and Andy Mills and Jim Abrams as vice chairmen. 

Medline has promoted Jim Boyle to serve as its next CEO, and Jim Pigott as president & COO, effective Oct. 1, culminating a five-year succession planning process. 

“Jim Boyle and Jim Pigott have been instrumental in Medline’s growth and success during their nearly 60 years combined within the organization, and we are excited for them to lead us into the future,” said Charlie Mills. “In blending Medline’s high-performance culture and customer-centric approach with their extensive understanding of healthcare, they are perfectly suited to propel Medline forward while continuing to build upon our rich legacy.” 

Boyle joined Medline in 1996 and has served as executive vice president since 2018, managing the company’s customer base of more than 5,000 health care providers across the continuum of care and overseeing more than $21 billion of annual sales. 

Pigott joined Medline in 1992 and most recently served as executive vice president, where he oversaw the strategy and execution of Medline’s 27 product divisions, comprised of more than 20 manufacturing sites and 14,000 employees.  

Founded in 1966, Medline is a global health care company with 56 years of consecutive sales growth, more than $21 billion in annual sales and more than 35,000 employees.